Abstract
Osteoarthritis (OA) most commonly affects knee joints, and the next most commonly affected sites are the hands and hips. Three distinct hand OA phenotypes have been described: erosive hand OA (EHOA), nodal hand OA — also known as non-erosive hand OA (non-EHOA) — and first carpometacarpal joint OA. EHOA predominantly affects women and is the most aggressive form of hand OA, characterized by a severe clinical onset and progression, leading to joint damage, disability and reduction of quality of life. Clinical signs of inflammation associated with EHOA include the acute onset of pain, swelling and redness. Moreover, EHOA is characterized by radiographic features such as central erosion, saw-tooth and gull-wing lesions and, rarely, ankylosis. The aim of this Review is to report the latest findings on epidemiology, clinical features, pathology and aetiopathogenesis, biomarkers, imaging modalities and treatments for EHOA. The ongoing development of new hand OA classification criteria should facilitate standardization between studies.
Key points
-
Erosive hand osteoarthritis (EHOA) is a severe form of hand OA, and evidence suggests that it is characterized by genetic predisposition involving HLA, IL1B and SERPINA1 genes.
-
The radiological hallmark of EHOA is central erosion of the joint, and both radiography and ultrasonography are useful tools for the detection of EHOA.
-
Serological and synovial-fluid biomarkers such as soluble IL-2 receptor and myeloperoxidase are identifiable in EHOA, confirming the role of inflammation in this aggressive form.
-
EHOA biomarkers that are useful in clinical practice have not yet been identified.
-
EHOA is characterized by the presence of signs of inflammation, which correlates with symptoms and the appearance of bone erosions.
-
Currently, no specific treatments are available to slow disease progression in EHOA.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vina, E. R. & Kwoh, C. K. Epidemiology of osteoarthritis: literature update. Curr. Opin. Rheumatol. 30, 160–167 (2018).
Cross, M. et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 73, 1323–1330 (2014).
Belluzzi, E. et al. Contribution of infrapatellar fat pad and synovial membrane to knee osteoarthritis pain. Biomed. Res. Int. 2019, 6390182 (2019).
Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 2, 16072 (2016).
Hunter, D. J. & Bierma-Zeinstra, S. Osteoarthritis. Lancet 393, 1745–1759 (2019).
Marshall, M., Watt, F. E., Vincent, T. L. & Dziedzic, K. Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management. Nat. Rev. Rheumatol. 14, 641–656 (2018).
Ramonda, R., Frallonardo, P., Musacchio, E., Vio, S. & Punzi, L. Joint and bone assessment in hand osteoarthritis. Clin. Rheumatol. 33, 11–19 (2014).
Punzi, L., Ramonda, R. & Sfriso, P. Erosive osteoarthritis. Best Pract. Res. Clin. Rheumatol. 18, 739–758 (2004).
Altman, R. et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 33, 1601–1610 (1990).
Haugen, I. K. et al. Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis. RMD Open 6, e001265 (2020).
Zhang, W. et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann. Rheum. Dis. 68, 8–17 (2009).
Punzi, L., Frigato, M., Frallonardo, P. & Ramonda, R. Inflammatory osteoarthritis of the hand. Best Pract. Res. Clin. Rheumatol. 24, 301–312 (2010).
Belhorn, L. R. & Hess, E. V. Erosive osteoarthritis. Semin. Arthritis Rheum. 22, 298–306 (1993).
Crain, D. C. Interphalangeal osteoarthritis: characterized by painful, inflammatory episodes resulting in deformity of the proximal and distal articulations. JAMA 175, 1049–1053 (1961).
Ehrlich, G. E. Inflammatory osteoarthritis. I. The clinical syndrome. J. Chronic Dis. 25, 317–328 (1972).
Ehrlich, G. E. Osteoarthritis beginning with inflammation: definitions and correlations. JAMA 232, 157–159 (1975).
Verbruggen, G., Goemaere, S. & Veys, E. M. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin. Rheumatol. 21, 231–243 (2002).
Verbruggen, G. & Veys, E. M. Numerical scoring systems for the progression of osteoarthritis of the finger joints. Rev. Rhum. Engl. Ed. 62, 27s–32s (1995).
Marshall, M. et al. Erosive osteoarthritis: a more severe form of radiographic hand osteoarthritis rather than a distinct entity? Ann. Rheum. Dis. 74, 136–141 (2015).
Haugen, I. K. et al. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype? Osteoarthritis Cartilage 24, 647–654 (2016).
Kortekaas, M. C., Kwok, W. Y., Reijnierse, M., Stijnen, T. & Kloppenburg, M. Brief report: association of inflammation with development of erosions in patients with hand osteoarthritis: a prospective ultrasonography study. Arthritis Rheumatol. 68, 392–397 (2016).
Mancarella, L. et al. Ultrasound detected inflammation is associated with the development of new bone erosions in hand osteoarthritis: a longitudinal study over 3.9 years. Osteoarthritis Cartilage 23, 1925–1932 (2015).
Haugen, I. K. et al. Increasing synovitis and bone marrow lesions are associated with incident joint tenderness in hand osteoarthritis. Ann. Rheum. Dis. 75, 702–708 (2016).
Iagnocco, A. et al. High resolution ultrasonography in detection of bone erosions in patients with hand osteoarthritis. J. Rheumatol. 32, 2381–2383 (2005).
Kortekaas, M. C., Kwok, W. Y., Reijnierse, M., Huizinga, T. W. & Kloppenburg, M. In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann. Rheum. Dis. 72, 930–934 (2013).
Vlychou, M., Koutroumpas, A., Malizos, K. & Sakkas, L. I. Ultrasonographic evidence of inflammation is frequent in hands of patients with erosive osteoarthritis. Osteoarthritis Cartilage 17, 1283–1287 (2009).
Grainger, A. J. et al. MR imaging of erosions in interphalangeal joint osteoarthritis: is all osteoarthritis erosive? Skeletal Radiol. 36, 737–745 (2007).
Haugen, I. K. et al. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis. Ann. Rheum. Dis. 75, 117–123 (2016).
Ramonda, R. et al. Serological markers of erosive hand osteoarthritis. Eur. J. Int. Med. 24, 11–15 (2013).
Oliviero, F., Ramonda, R., & Punzi, L. New horizons in osteoarthritis. Swiss Med. Wkly. 140, w13098 (2010).
Stern, A. G. et al. Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta. Osteoarthritis Cartilage 11, 394–402 (2003).
Ramonda, R. et al. Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy. Scand. J. Rheumatol. 40, 139–144 (2011).
Punzi, L. et al. Coll21–, Coll21–NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis Cartilage 20, 557–561 (2012).
Kwok, W. Y. et al. Erosive hand osteoarthritis: its prevalence and clinical impact in the general population and symptomatic hand osteoarthritis. Ann. Rheum. Dis. 70, 1238 (2011).
Bijsterbosch, J. et al. Clinical burden of erosive hand osteoarthritis and its relationship to nodes. Ann. Rheum. Dis. 69, 1784–1788 (2010).
Pattrick, M., Aldridge, S., Hamilton, E., Manhire, A. & Doherty, M. A controlled study of hand function in nodal and erosive osteoarthritis. Ann. Rheum. Dis. 48, 978–982 (1989).
Cobby, M., Cushnaghan, J., Creamer, P., Dieppe, P. & Watt, I. Erosive osteoarthritis: is it a separate disease entity? Clin. Radiol. 42, 258–263 (1990).
Cavasin, F. et al. [Prevalence of erosive osteoarthritis of the hand in a population from Venetian area]. Reumatismo 56, 46–50 (2004).
Wittoek, R., Cruyssen, B. V. & Verbruggen, G. Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis. Arthritis Rheum. 64, 1430–1436 (2012).
Kwok, W. Y. et al. Comparison of clinical burden between patients with erosive hand osteoarthritis and inflammatory arthritis in symptomatic community-dwelling adults: the Keele clinical assessment studies. Rheumatology 52, 2260–2267 (2013).
Marshall, M. et al. Subsets of symptomatic hand osteoarthritis in community-dwelling older adults in the United Kingdom: prevalence, inter-relationships, risk factor profiles and clinical characteristics at baseline and 3-years. Osteoarthritis Cartilage 21, 1674–1684 (2013).
Kwok, W. Y. et al. The prevalence of erosive osteoarthritis in carpometacarpal joints and its clinical burden in symptomatic community-dwelling adults. Osteoarthritis Cartilage 22, 756–763 (2014).
Haugen, I. K. et al. Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study. Ann. Rheum. Dis. 70, 1581–1586 (2011).
McAlindon, T. E. et al. Erosive hand osteoarthritis: incidence and predictive characteristics among participants in the osteoarthritis initiative. Arthritis Rheumatol. 73, 2015–2024 (2021).
Doherty, M., Hutton, C., & Bayliss, M. T. in Oxford Textbook of Rheumatology Vol.2 (eds Isenberg, D. A., Maddison, P. J., Woo, P. & Glass, D. N.) 959–983 (Oxford Medical Publications, 1993).
Punzi, L., Favero, M., Frallonardo, P. & Ramonda, R. Time to redefine erosive osteoarthritis. RMD Open 1, e000105 (2015).
Keats, T. E., Johnstone, W. H. & O’Brien, W. M. Large joint destruction in erosive osteoarthritis. Skeletal Radiol. 6, 267–269 (1981).
Marks, P. H. & Donaldson, M. L. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee. Arthroscopy 21, 1342–1347 (2005).
Kalichman, L. & Hunter, D. J. Lumbar facet joint osteoarthritis: a review. Semin. Arthritis Rheum. 37, 69–80 (2007).
Duarte-Salazar, C., Marín-Arriaga, N. & Miranda-Duarte, A. The high clinical burden of erosive hand osteoarthritis is associated with clinical findings, pain, and radiographic severity. Reumatol. Clin. https://doi.org/10.1016/j.reuma.2021.03.002 (2021).
Visser, A. W. et al. Instruments measuring pain, physical function, or patient’s global assessment in hand osteoarthritis: a systematic literature search. J. Rheumatol. 42, 2118–2134 (2015).
Perrotta, F. M., Scriffignano, S., De Socio, A. & Lubrano, E. An assessment of hand erosive osteoarthritis: correlation of radiographic severity with clinical, functional and laboratory findings. Rheumatol. Ther. 6, 125–133 (2019).
Michon, M., Maheu, E. & Berenbaum, F. Assessing health-related quality of life in hand osteoarthritis: a literature review. Ann. Rheum. Dis. 70, 921–928 (2011).
Bodhani, A. R., Suryavanshi, M., Medema, J. & Fuldeore, M. Health related quality of life among patients with erosive hand osteoarthritis in The United States. Osteoarthritis Cartilage 24, S238 (2016).
Peter, J. B., Pearson, C. M. & Marmor, L. Erosive osteoarthritis of the hands. Arthritis Rheum. 9, 365–388 (1966).
Favero, M., Perino, G., Valente, M. L., Tiengo, C. & Ramonda, R. Radiological and histological analysis of two replaced interphalangeal joints with active subchondral bone resorption in erosive hand osteoarthritis: a novel mechanism? Skeletal Radiol. 46, 385–391 (2017).
Pritzker, K. P. et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14, 13–29 (2006).
Scanzello, C. R. et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum. 63, 391–400 (2011).
Stecher, R. M. & Hersh, A. H. Heberden’s nodes: the mechanism of inheritance in hypertrophic arthritis of the fingers. J. Clin. Invest. 23, 699–704 (1944).
Cicuttini, F. M. & Spector, T. D. Genetics of osteoarthritis. Ann. Rheum. Dis. 55, 665–667 (1996).
Fernández-Moreno, M., Rego, I., Carreira-Garcia, V. & Blanco, F. J. Genetics in osteoarthritis. Curr. Genomics 9, 542–547 (2008).
Hämäläinen, S. et al. Genetic influences on hand osteoarthritis in Finnish women — a replication study of candidate genes. PLoS One 9, e97417–e97417 (2014).
Ross, J. M. et al. Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis. J. Rheumatol. 30, 121–125 (2003).
Carroll, G. J. HFE gene mutations are associated with osteoarthritis in the index or middle finger metacarpophalangeal joints. J. Rheumatol. 33, 741–743 (2006).
Hämäläinen, S., Solovieva, S., Vehmas, T., Leino-Arjas, P. & Hirvonen, A. Variations in the TNFα gene and their interactions with the IL4R and IL10 genes in relation to hand osteoarthritis. BMC Musculoskelet. Disord. 15, 311 (2014).
Zhu, X. et al. Association of aspartic acid repeat polymorphism in the asporin gene with osteoarthritis of knee, hip, and hand: a PRISMA-compliant meta-analysis. Medicine 97, e0200 (2018).
Zhai, G. et al. A genome-wide association study suggests that a locus within the ataxin 2 binding protein 1 gene is associated with hand osteoarthritis: the Treat-OA consortium. J. Med. Genet. 46, 614–616 (2009).
Kerkhof, H. J. et al. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum. 62, 499–510 (2010).
Taipale, M., Solovieva, S., Leino-Arjas, P. & Männikkö, M. Functional polymorphisms in asporin and CILP together with joint loading predispose to hand osteoarthritis. BMC Genet. 18, 108 (2017).
Pattrick, M., Manhire, A., Ward, A. M. & Doherty, M. HLA-A, B antigens and alpha 1-antitrypsin phenotypes in nodal generalised osteoarthritis and erosive osteoarthritis. Ann. Rheum. Dis. 48, 470–475 (1989).
Punzi, L., Bertazzolo, N., Pianon, M., Michelotto, M. & Todesco, S. Soluble interleukin 2 receptors and treatment with hydroxychloroquine in erosive osteoarthritis. J. Rheumatol. 23, 1477–1478 (1996).
Strand, M. P., Neogi, T., Niu, J., Felson, D. T. & Haugen, I. K. Association between metabolic syndrome and radiographic hand osteoarthritis: data from a community-based longitudinal cohort study. Arthritis Care Res. 70, 469–474 (2018).
Magnusson, K. et al. Diabetes is associated with increased hand pain in erosive hand osteoarthritis: data from a population-based study. Arthritis Care Res. 67, 187–195 (2015).
Marshall, M. et al. Metabolic risk factors and the incidence and progression of radiographic hand osteoarthritis: a population-based cohort study. Scand. J. Rheumatol. 48, 52–63 (2019).
Addimanda, O. et al. Clinical associations in patients with hand osteoarthritis. Scand. J. Rheumatol. 41, 310–313 (2012).
Bray, C. et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ 115, 317–321 (2016).
Olejârovâ, M., Kupka, K., Pavelka, K., Gatterovâ, J. & Stolfa, J. Comparison of clinical, laboratory, radiographic, and scintigraphic findings in erosive and nonerosive hand osteoarthritis: results of a two-year study. Jt. Bone Spine 67, 107–112 (2000).
Punzi, L. et al. Value of C reactive protein in the assessment of erosive osteoarthritis of the hand. Ann. Rheum. Dis. 64, 955–957 (2005).
Mathiessen, A., Østerås, N., Kvien, T., Hammer, H. & Haugen, I. Erosive status has no effect on systemic inflammatory biomarkers in hand osteoarthritis. Osteoarthritis Cartilage 24, S422 (2016).
Rovetta, G., Monteforte, P., Grignolo, M. C., Brignone, A. & Buffrini, L. Hematic levels of type I collagen C-telopeptide in erosive versus nonerosive osteoarthritis of the hands. Int. J. Tissue React. 25, 25–28 (2003).
Silvestri, T., Pulsatelli, L., Dolzani, P., Punzi, L. & Meliconi, R. Analysis of cartilage biomarkers in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis Cartilage 12, 843–845 (2004).
Filková, M. et al. Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthritis Cartilage 17, 1615–1619 (2009).
Fioravanti, A., Tenti, S., Pulsatelli, L. & Addimanda, O. Could myeloperoxidase represent a useful biomarker for erosive osteoarthritis of the hand? Scand. J. Rheumatol. 47, 515–517 (2018).
Davies, M. J. & Hawkins, C. L. The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease. Antioxid. Redox Signal. 32, 957–981 (2020).
Fioravanti, A. et al. Can adipokines serum levels be used as biomarkers of hand osteoarthritis? Biomarkers 23, 265–270 (2018).
Laiguillon, M.-C. et al. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res. Ther. 16, R38 (2014).
Zhang, Z. et al. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum. 62, 1993–2003 (2010).
Kropackova, T. et al. Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain. BMC Musculoskelet. Disord. 19, 264 (2018).
Oliviero, F. et al. Levels of inflammatory cytokines and metalloproteinases are increased in knee synovial fluid of patients with concomitant erosive hand osteoarthritis. Clin. Exp. Rheumatol. 38, 800 (2020).
Martel, W., Stuck, K. J., Dworin, A. & Hylland, R. Erosive osteoarthritis and psoriatic arthritis: a radiologic comparison in the hand, wrist, and foot. AJR Am. J. Roentgenol. 134, 125–135 (1980).
Addimanda, O. et al. Clinical and radiographic distribution of structural damage in erosive and nonerosive hand osteoarthritis. Arthritis Care Res. 64, 1046–1053 (2012).
Kellgren, J. H. & Lawrence, J. S. The epidemiology of chronic rheumatism in Atlas of Standard Radiographs (ed. Kellgren, J. H.) 10–11 (FA Davis, Philadelphia, 1963).
Kallman, D. A., Wigley, F. M., Scott, W. W. Jr., Hochberg, M. C. & Tobin, J. D. New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. Arthritis Rheum. 32, 1584–1591 (1989).
Altman, R. D. & Gold, G. E. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 15, A15–A16 (2007).
Altman, R. D. et al. Radiographic assessment of progression in osteoarthritis. Arthritis Rheum. 30, 1214–1225 (1987).
Altman, R. D., Hochberg, M., Murphy, W. A. Jr., Wolfe, F. & Lequesne, M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage 3, 3–70 (1995).
Grassi, W., Filippucci, E., Farina, A. & Cervini, C. Sonographic imaging of the distal phalanx. Semin. Arthritis Rheum. 29, 379–384 (2000).
Vlychou, M., Koutroumpas, A., Malizos, K. & Sakkas, L. I. Ultrasonographic evidence of inflammation is frequent in hands of patients with erosive osteoarthritis. Osteoarthritis Cartilage 17, 1283–1287 (2009).
Ramonda, R. et al. A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting. Clin. Rheumatol. 35, 2079–2086 (2016).
Mancarella, L. et al. Ultrasound-detected synovitis with power Doppler signal is associated with severe radiographic damage and reduced cartilage thickness in hand osteoarthritis. Osteoarthritis Cartilage 18, 1263–1268 (2010).
Hayashi, D., Roemer, F. W. & Guermazi, A. Recent advances in research imaging of osteoarthritis with focus on MRI, ultrasound and hybrid imaging. Clin. Exp. Rheumatol. 36, 43–52 (2018).
Scanzello, C. R. & Goldring, S. R. The role of synovitis in osteoarthritis pathogenesis. Bone 51, 249–257 (2012).
Haugen, I. K. et al. Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score. Ann. Rheum. Dis. 70, 1033–1038 (2011).
Liu, R. et al. Bone marrow lesions on magnetic resonance imaging in hand osteoarthritis are associated with pain and interact with synovitis. Osteoarthritis Cartilage 25, 1093–1099 (2017).
Haugen, I. K. et al. Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system. J. Rheumatol. 41, 386–391 (2014).
Haugen, I. K. et al. The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS). J. Rheumatol. 42, 2486–2491 (2015).
Allado, E. et al. Assessment of structural lesions, synovitis and bone marrow lesions in erosive hand osteoarthritis on MRI (0.3 T) compared to the radiographic anatomical Verbruggen-Veys score. PLoS One 15, e0234972 (2020).
Ulas, S. T. et al. Susceptibility-weighted MR imaging to improve the specificity of erosion detection: a prospective feasibility study in hand arthritis. Skeletal Radiol. 48, 721–728 (2019).
Kloppenburg, M. et al. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1alpha and anti-interleukin-1beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann. Rheum. Dis. 78, 413–420 (2019).
Kloppenburg, M. Hand osteoarthritis-nonpharmacological and pharmacological treatments. Nat. Rev. Rheumatol. 10, 242–251 (2014).
Kloppenburg, M. et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann. Rheum. Dis. 78, 16–24 (2019).
Kroon, F. P. B., Carmona, L., Schoones, J. W. & Kloppenburg, M. Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis. RMD Open 4, e000734 (2018).
Utsinger, P. D., Resnick, D., Shapiro, R. F. & Wiesner, K. B. Roentgenologic, immunologic, and therapeutic study of erosive (inflammatory) osteoarthritis. Arch. Intern. Med. 138, 693–697 (1978).
Favero, M. et al. Efficacy and safety of ultrasound-guided intra-articular glucocorticoid injection in erosive hand osteoarthritis. Pain Med. 22, 1229–1232 (2021).
Favero, M., Ramonda, R. & Rossato, M. Efficacy of intra-articular corticosteroid injection in erosive hand osteoarthritis: infrared thermal imaging. Rheumatology 56, 86 (2017).
Kolasinski, S. L. et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheum. 72, 220–233 (2020).
Lee, W. et al. Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. 70, 1320–1325 (2018).
Saviola, G. et al. Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study. Mod. Rheumatol. 22, 256–263 (2012).
Kedor, C. et al. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study — a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open 7, e001660 (2021).
Ferrero, S. et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin. Arthritis Rheum. 51, 831–838 (2021).
Magnano, M. D. et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J. Rheumatol. 34, 1323–1327 (2007).
Aitken, D. et al. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis — the HUMOR trial. Osteoarthritis Cartilage 26, 880–887 (2018).
Verbruggen, G., Wittoek, R., Vander Cruyssen, B. & Elewaut, D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann. Rheum. Dis. 71, 891–898 (2012).
Kloppenburg, M. et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 77, 1757–1764 (2018).
Kroon, F. et al. Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis. Scand. J. Rheumatol. 49, 167–168 (2020).
Fioravanti, A., Fabbroni, M., Cerase, A. & Galeazzi, M. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol. Int. 29, 961–965 (2009).
Bacconnier, L., Jorgensen, C. & Fabre, S. Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann. Rheum. Dis. 68, 1078 (2009).
Author information
Authors and Affiliations
Contributions
All authors contributed equally to all aspects of the article.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Rheumatology thanks Michelle Marshall, Ruth Wittoek and the other, anonymous, reviewer for their contribution to the peer review of this work.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Glossary
- Osteophytes
-
Bone spurs that grow along bone–joint margins.
- Subchondral cyst
-
Fluid-filled sac occurring in subchondral bone.
- Subchondral sclerosis
-
Hardening of the bone just below the cartilage surface.
- Ankylosis
-
Fusion of the joint.
- Paraesthesia
-
Abnormal skin sensation (such as numbness or a burning feeling).
- Gradient echo MRI sequence
-
The gradient echo sequence is an excitation sequence for rapid image acquisition.
Rights and permissions
About this article
Cite this article
Favero, M., Belluzzi, E., Ortolan, A. et al. Erosive hand osteoarthritis: latest findings and outlook. Nat Rev Rheumatol 18, 171–183 (2022). https://doi.org/10.1038/s41584-021-00747-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-021-00747-3
This article is cited by
-
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial
Nature Medicine (2024)
-
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Scientific Reports (2024)
-
Erosive Hand Osteoarthritis: Recent Advances and Future Treatments
Current Rheumatology Reports (2024)
-
Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a Mendelian randomization study
BMC Public Health (2023)
-
Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study
Aging Clinical and Experimental Research (2022)